As of 2024-12-12, the Intrinsic Value of Ascelia Pharma AB (ACE.ST) is
-9.23 SEK. This ACE.ST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 21.40 SEK, the upside of Ascelia Pharma AB is
-143.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-9.23 SEK
Intrinsic Value
ACE.ST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-9.23 - -9.23 |
-9.23 |
-143.12% |
| P/E |
(58.90) - (57.76) |
(59.38) |
-377.5% |
| DDM - Stable |
(33.31) - 1,949.58 |
958.13 |
4377.3% |
| DDM - Multi |
(59.08) - 2,674.58 |
(120.49) |
-663.1% |
ACE.ST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
722.41 |
| Beta |
0.60 |
| Outstanding shares (mil) |
33.76 |
| Enterprise Value (mil) |
653.31 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.90% |
| Cost of Debt |
5.00% |
| WACC |
5.89% |